137 related articles for article (PubMed ID: 32285234)
1. Alcohol use is not a significant contributor to myelodysplastic syndromes.
Duffy EA; Nguyen PL; Cioc A; Warlick E; Roesler MA; Poynter JN
Cancer Causes Control; 2020 Jun; 31(6):549-557. PubMed ID: 32285234
[TBL] [Abstract][Full Text] [Related]
2. Alcohol consumption and risk of myelodysplastic syndromes: a case-control study.
Liu P; Holman CD; Jin J; Zhang M
Cancer Causes Control; 2016 Feb; 27(2):209-16. PubMed ID: 26590915
[TBL] [Abstract][Full Text] [Related]
3. The association between non-steroidal anti-inflammatory drugs (NSAIDs) and myelodysplastic syndromes in the Adults in Minnesota with Myelodysplastic Syndromes (AIMMS) Study.
Hubbard AK; Richardson M; Rosesler MA; Cioc A; Nguyen PL; Warlick E; Poynter JN
Leuk Lymphoma; 2021 Jun; 62(6):1474-1481. PubMed ID: 33416407
[TBL] [Abstract][Full Text] [Related]
4. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
[TBL] [Abstract][Full Text] [Related]
5. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.
Poynter JN; Richardson M; Blair CK; Roesler MA; Hirsch BA; Nguyen P; Cioc A; Warlick E; Cerhan JR; Ross JA
Cancer Epidemiol; 2016 Feb; 40():134-40. PubMed ID: 26720913
[TBL] [Abstract][Full Text] [Related]
6. Smoking and alcohol and subsequent risk of myelodysplastic syndromes in Japan: the Japan Public Health Centre-based Prospective Study.
Ugai T; Matsuo K; Sawada N; Iwasaki M; Yamaji T; Shimazu T; Sasazuki S; Inoue M; Kanda Y; Tsugane S;
Br J Haematol; 2017 Sep; 178(5):747-755. PubMed ID: 28714213
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).
Yarosh R; Roesler MA; Murray T; Cioc A; Hirsch B; Nguyen P; Warlick E; Poynter JN
Cancer Causes Control; 2021 Mar; 32(3):241-250. PubMed ID: 33392905
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for myelodysplastic syndromes: a case-control study in Greece.
Dalamaga M; Petridou E; Cook FE; Trichopoulos D
Cancer Causes Control; 2002 Sep; 13(7):603-8. PubMed ID: 12296507
[TBL] [Abstract][Full Text] [Related]
9. Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS).
Du Y; Fryzek J; Sekeres MA; Taioli E
Leuk Res; 2010 Jan; 34(1):1-5. PubMed ID: 19747728
[TBL] [Abstract][Full Text] [Related]
10. Tea consumption reduces the risk of de novo myelodysplastic syndromes.
Liu P; Zhang M; Jin J; Holman CD
Leuk Res; 2015 Feb; 39(2):164-9. PubMed ID: 25529769
[TBL] [Abstract][Full Text] [Related]
11. Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece.
Avgerinou C; Giannezi I; Theodoropoulou S; Lazaris V; Kolliopoulou G; Zikos P; Alamanos Y; Leotsinidis M; Symeonidis A
Hematology; 2017 Aug; 22(7):419-429. PubMed ID: 28102107
[TBL] [Abstract][Full Text] [Related]
12. Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population.
Lv L; Lin G; Gao X; Wu C; Dai J; Yang Y; Zou H; Sun H; Gu M; Chen X; Fu H; Bao L
Am J Hematol; 2011 Feb; 86(2):163-9. PubMed ID: 21264898
[TBL] [Abstract][Full Text] [Related]
13. Alcohol consumption and risk of myelodysplastic syndromes: A meta-analysis of epidemiological studies.
Jin J; Yu M; Hu C; Ye L; Xie L; Chen F; Zhuang Z; Tong H
Mol Clin Oncol; 2014 Nov; 2(6):1115-1120. PubMed ID: 25279208
[TBL] [Abstract][Full Text] [Related]
14. A case-control study of myelodysplastic syndromes in Belgrade (Serbia Montenegro).
Pekmezovic T; Suvajdzic Vukovic N; Kisic D; Grgurevic A; Bogdanovic A; Gotic M; Bakrac M; Brkic N
Ann Hematol; 2006 Aug; 85(8):514-9. PubMed ID: 16691397
[TBL] [Abstract][Full Text] [Related]
15. Association between mitochondrial DNA haplogroup and myelodysplastic syndromes.
Poynter JN; Richardson M; Langer E; Hooten AJ; Roesler M; Hirsch B; Nguyen PL; Cioc A; Warlick E; Ross JA
Genes Chromosomes Cancer; 2016 Sep; 55(9):688-93. PubMed ID: 27121678
[TBL] [Abstract][Full Text] [Related]
16. Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes.
Linabery AM; Roesler MA; Richardson M; Warlick ED; Nguyen PL; Cioc AM; Poynter JN
Cancer Epidemiol; 2022 Feb; 76():102090. PubMed ID: 34995873
[TBL] [Abstract][Full Text] [Related]
17. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
Rollison DE; Shain KH; Lee JH; Hampras SS; Fulp W; Fisher K; Al Ali NH; Padron E; Lancet J; Xu Q; Olesnyckyj M; Kenvin L; Knight R; Dalton W; List A; Komrokji RS
Cancer Med; 2016 Jul; 5(7):1694-701. PubMed ID: 27098006
[TBL] [Abstract][Full Text] [Related]
18. A case-control study of myelodysplastic syndromes among Japanese men and women.
Ido M; Nagata C; Kawakami N; Shimizu H; Yoshida Y; Nomura T; Mizoguchi H
Leuk Res; 1996 Sep; 20(9):727-31. PubMed ID: 8947581
[TBL] [Abstract][Full Text] [Related]
19. Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan.
Ugai T; Matsuo K; Sawada N; Iwasaki M; Yamaji T; Shimazu T; Goto A; Inoue M; Kanda Y; Tsugane S;
Int J Cancer; 2018 Mar; 142(6):1130-1138. PubMed ID: 29076523
[TBL] [Abstract][Full Text] [Related]
20. Relative risk of myelodysplastic syndromes in patients with autoimmune disorders in the General Practice Research Database.
Wilson AB; Neogi T; Prout M; Jick S
Cancer Epidemiol; 2014 Oct; 38(5):544-9. PubMed ID: 25189344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
